32 results on '"Bavand, anahita"'
Search Results
2. PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals
3. Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine
4. Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran
5. Assessment of COVID‐19 Vaccine Impact on Women's Menstrual Health within an 18‐Month Follow‐Up.
6. Determination of COVID-19 Late Disorders as Possible Long-COVID and/or Vaccination Consequences.
7. Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals
8. No evidence of occult HBV infection in population born after mass vaccination
9. Potential Protectivity of a Conjugated COVID-19 Vaccine against Tetanus.
10. The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID‐19 vaccine regimens.
11. Safety, Immunogenicity, and Antibody Persistence of COVID-19 Boosters in BBIP-CorV Immunized Individuals with Comorbidities
12. Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study
13. A Landscape on Disorders Following Different COVID-19 Vaccination: A Systematic Review of Iranian Case Reports
14. Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women
15. A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population.
16. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran
17. Frequency and subtype of BK virus infection in Iranian patients infected with HIV
18. Determination of Human Papillomavirus Type 18 Lineage of E6: A Population Study from Iran
19. Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients
20. Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
21. Prevalence of Toxoplasma gondii Antibodies and DNA in Iranian HIV Patients
22. 5-ALA–induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients
23. Seroprevalence of Hepatitis A among Children and Young Adults Residing in Tehran, Iran: Implication for HAV Vaccination
24. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors
25. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran
26. Prevalence of Toxoplasma gondii Antibodies and DNA in Iranian HIV Patients.
27. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients
28. No Role of Herpes Simplex Virus Type 2 (HSV-2) Infection on HIV Progression in Naïve HIV Patients.
29. Frequency and subtype of BK virus infection in Iranian patients infected with HIV
30. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients.
31. BK Viremia among Iranian Renal Transplant Candidates.
32. Occult hepatitis C virus infection in Iranian hemodialysis patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.